Clinical Trials for Tuberculosis, Pulmonary

ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74

NCT ID: NCT06714513

This clinical trial is studying a new vaccine called ID93+GLA-SE to see if it is safe and effective in preventing tuberculosis (TB) in older adults aged 55 to 74. Participants will receive three in...

Shortened Regimen for Drug-susceptible TB in Children

NCT ID: NCT06253715

This clinical trial is studying a new, shorter treatment for drug-susceptible tuberculosis (TB) in children under 10 years old. Currently, treating TB usually takes four to six months, but research...

Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline

NCT ID: NCT06477185

This clinical trial is studying the effectiveness of a medication called doxycycline in preventing lung damage and breathing problems caused by tuberculosis (TB) in patients with advanced disease. ...

Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

NCT ID: NCT06845618

This clinical trial is exploring a new method to monitor tuberculosis (TB) treatment by looking at specific DNA from the bacteria that cause TB, called Mycobacterium tuberculosis. Researchers want ...

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

NCT ID: NCT06585358

This clinical trial, called DoseTB, is exploring a new way to personalize tuberculosis (TB) treatment using a method called model-informed precision dosing (MIPD). The goal is to ensure patients re...

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

NCT ID: NCT06441006

The PRISM-TB trial is a research study aimed at finding effective treatment strategies for patients with a specific type of tuberculosis (TB) called fluoroquinolone-susceptible multidrug-resistant/...

Clinic-based Versus Hotspot-focused Active TB Case Finding

NCT ID: NCT05285202

This clinical trial is studying two different strategies to find and treat tuberculosis (TB) in communities near a public health facility in Uganda. One approach involves screening people who are a...

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

NCT ID: NCT04752592

This clinical trial is studying a new quick test called SeroSelectTB that aims to help doctors identify active tuberculosis (TB) illness more easily and quickly at local healthcare centers in count...

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB

NCT ID: NCT05556746

The PRESCIENT trial is a study designed to compare a new treatment plan for drug-susceptible pulmonary tuberculosis (TB) with the standard therapy that is currently used. The new treatment includes...

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

NCT ID: NCT05766267

This clinical trial is studying new treatment options for pulmonary tuberculosis (TB), a serious lung infection. Researchers are comparing two shorter treatment regimens, each lasting 17 weeks, wit...

Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India

NCT ID: NCT06526221

This clinical trial is studying a new way to help doctors identify patients with tuberculosis (TB) who may not be taking their medications as prescribed. The researchers believe that testing urine ...

Post TB Sequelae Study

NCT ID: NCT06744179

Therapeutic ID93 + GLA-SE Vaccination in Participants with Rifampicin-Susceptible Pulmonary TB

NCT ID: NCT06205589

This clinical trial is studying a new vaccine called ID93 + GLA-SE to see if it can improve treatment outcomes for people with pulmonary tuberculosis (TB) who are also living with HIV. The vaccine ...

A Systemic Screening for TB Disease in High-risk Groups in Barcelona

NCT ID: NCT06706596

This clinical trial, titled "A Systemic Screening for TB Disease in High-risk Groups in Barcelona," is focused on finding and testing people who are at high risk for active pulmonary tuberculosis (...

Pharmacist-Led Intervention to Improve TB Treatment and Outcomes

NCT ID: NCT06608069

This clinical trial is studying how a pharmacist-led educational program can help patients with pulmonary tuberculosis (TB) and those who are also living with HIV. The main goal is to find out if t...

The INSTITUT Study

NCT ID: NCT06084715

The INSTITUT Study is looking at how nutritional support can impact the treatment outcomes for people with tuberculosis (TB) in two West African countries: Benin and Togo. In Benin, patients with T...

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

NCT ID: NCT04147286

This clinical trial is studying whether a medication called atorvastatin can help reduce lung inflammation in adults who have successfully completed treatment for tuberculosis (TB). Researchers wan...

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

NCT ID: NCT06526039

This clinical trial is looking at a new treatment plan for patients with a specific type of tuberculosis (TB) known as rifampicin-resistant, isoniazid-susceptible pulmonary TB. The study aims to fi...

Comparative Efficacy of CUS, CXR and CAD in TB Diagnosis in LMIC

NCT ID: NCT06409780

This clinical trial is studying how well different imaging methods can diagnose pulmonary tuberculosis (TB), a serious lung infection that is still a big health issue in many low- and middle-income...

Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB

NCT ID: NCT06392594

This clinical trial is investigating how well two tests, called Xpert MTB/RIF and XDR Assay, can diagnose pulmonary tuberculosis (TB) and identify drug-resistant forms of the disease. TB is a serio...